Denmark's Smoking Rate and E-cigarette Use Rise with Flavor Ban

Feb.15.2023
Denmark's Smoking Rate and E-cigarette Use Rise with Flavor Ban
Danish smoking and e-cigarette use increased from 2020 to 2022, despite a flavor ban in 2022, according to a report.

According to the latest data released by the Danish National Health Committee in February 2023, smoking and e-cigarette use have both increased in Denmark from 2020 to 2022. It is reported that a flavor ban in Denmark officially took effect on April 1, 2022.


A report has revealed the smoking rate in Denmark from 2020 to 2022.


The percentage of smokers has increased from 18% to 19%.


The percentage of smokers aged 15-29 years has increased from 23% to 25%.


The usage rate of electronic cigarettes has increased from 3% to 5%.


The usage rate of electronic cigarettes among individuals aged 15-29 is between 4% and 7%.


In the years 2020-2022, there was a significant increase in the number of fruit and candy/soft drink flavored electronic cigarettes.


The percentage of users of fruit-flavored electronic cigarettes has increased from 47% to 67%.


The percentage of candy and soft drink flavor users has increased from 21% to 32%.


The percentage of fruit-flavored e-cigarette users aged 15-29 increased from 67% to 83%.


The percentage of candy/soft drink flavor users aged 15-29 has increased from 32% to 41%.


However, the increase in Denmark's smoking rate failed to lead to an increase in the rate of quitting smoking. From 2020 to 2022, the number of e-cigarette users who completely quit smoking decreased from 41% to 38%. This indicates that the ban on electronic cigarettes may decrease their effectiveness as a smoking cessation tool.


Officials from a Danish health research institution have stated that even though Denmark has implemented a flavor ban, illegal e-cigarettes are still circulating through black markets and being sold to children and young people through social media. The Danish authorities do not have enough resources to handle the growing illegal market.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Thai Health Authorities: Nicotine Pouches Classified as Tobacco; Sales Must Comply with 2017 Act
Thai Health Authorities: Nicotine Pouches Classified as Tobacco; Sales Must Comply with 2017 Act
Thailand’s Disease Control Department has warned that nicotine pouches (“Snus”) are classified as tobacco products and must comply with the Tobacco Products Control Act B.E. 2560 (2017). Officials said they have received complaints about sales and promotional activities, and stressed that these products must not be displayed or promoted at points of sale.
Feb.02 by 2FIRSTS.ai
Singapore man, 21, assisting investigations after video allegedly shows him vaping on a bus
Singapore man, 21, assisting investigations after video allegedly shows him vaping on a bus
A 21-year-old man in Singapore is assisting with investigations after a video allegedly showing him vaping inside a bus went viral on social media. The Health Sciences Authority (HSA) said via its Instagram Stories that it had identified the man and seized e-vaporisers and 12 pods from his home on Feb 3. Vape-related penalties were strengthened from Sept 1, with first-time adult users liable to a $700 fine, and third-time offenders prosecuted and fined up to $2,000.
Feb.06
Bonnie Herzog:U.S. nicotine market seen at about $67B in revenue by 2035 as smoke-free expands
Bonnie Herzog:U.S. nicotine market seen at about $67B in revenue by 2035 as smoke-free expands
Goldman Sachs Managing Director Bonnie Herzog said the U.S. nicotine market is attractive and growing, with total revenue projected to reach about $67 billion by 2035. She expects cigarettes to account for a smaller share of revenue (47%) as smoke-free revenue expands and becomes a key driver of industry profit growth. Herzog said smoke-free products represent about 48% of U.S. nicotine volumes today and could rise to roughly 75% by 2035.
Mar.04 by 2FIRSTS.ai
Exclusive|Suspected China Tobacco Nicotine Oral Film Product Surfaces on Social Media
Exclusive|Suspected China Tobacco Nicotine Oral Film Product Surfaces on Social Media
China Tobacco Jiangsu IC appears to have developed a nicotine oral film product under the "Nanjing" brand, according to images circulating on Chinese social media. If confirmed, this could potentially mark China Tobacco's first oral nicotine product targeting the domestic market. The product's authenticity has not been officially verified, and no nicotine pouch products have been approved for sale in China.
Special Report
Feb.09
Philip Morris Japan adds “Electric Purple” to IQOS ILUMA i range, expands to convenience stores from Feb. 3
Philip Morris Japan adds “Electric Purple” to IQOS ILUMA i range, expands to convenience stores from Feb. 3
Philip Morris Japan (PMJ) said on Jan. 29 it has introduced “Electric Purple” as a new standard color option for its IQOS ILUMA i heated tobacco device lineup, covering three models with prices unchanged. The new color will be available from Jan. 29 via the company’s official online and store channels, with sales expanding to convenience stores and some tobacco retailers from Feb. 3.
Jan.29 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24